Aberrant protein glycosylation: Implications on diagnosis and Immunotherapy
Open Access
- 6 April 2023
- journal article
- review article
- Published by Elsevier in Biotechnology Advances
- Vol. 66, 108149
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology, Ministry of Science and Technology, India (IF180523, IF210078, TDP/BDTD/54/2021/General)
This publication has 179 references indexed in Scilit:
- Sialyl-Tn in Cancer: (How) Did We Miss the Target?Biomolecules, 2012
- Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cellsCell Death & Differentiation, 2011
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- Arabidopsis thaliana alpha1,2‐glucosyltransferase (ALG10) is required for efficient N‐glycosylation and leaf growthThe Plant Journal, 2011
- Suppression of Glucosylceramide Synthase Restores p53-Dependent Apoptosis in Mutant p53 Cancer CellsCancer Research, 2011
- Metabolism, Cell Surface Organization, and DiseaseCell, 2009
- Overexpression of DPAGT1 Leads to Aberrant N-Glycosylation of E-Cadherin and Cellular Discohesion in Oral CancerCancer Research, 2009
- Complex N-glycans or core 1-derived O-glycans are not required for the expression of stage-specific antigens SSEA-1, SSEA-3, SSEA-4, or LeY in the preimplantation mouse embryoGlycoconjugate Journal, 2008
- Recent insights into the biological roles of mucin-type O-glycosylationGlycoconjugate Journal, 2008
- The role of galectin-3 in cancer drug resistanceDrug Resistance Updates, 2007